These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 9824947
1. [The natural course of hepatitis B and hepatitis C virus infection]. Schwabe RF, Stremmel W. Praxis (Bern 1994); 1998 Oct 14; 87(42):1403-7. PubMed ID: 9824947 [Abstract] [Full Text] [Related]
2. Sister chromatid exchange and mitotic index in patients with cirrhosis related to hepatitis B and C viruses and in chronic carriers. Ucur A, Palanduz S, Cefle K, Ozturk S, Tutkan G, Vatansever S, Erden S, Karan MA, Erten N, Guler K, Tascioglu C. Hepatogastroenterology; 2003 Oct 14; 50(54):2137-40. PubMed ID: 14696481 [Abstract] [Full Text] [Related]
3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Leone N, Rizzetto M. Minerva Gastroenterol Dietol; 2005 Mar 14; 51(1):31-46. PubMed ID: 15756144 [Abstract] [Full Text] [Related]
4. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Hepatogastroenterology; 2003 Mar 14; 50(54):2022-7. PubMed ID: 14696457 [Abstract] [Full Text] [Related]
5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May 14; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
6. Clinical features of patients with HCC who are negative for both HBV and HCV markers. Watabe H, Shiratori Y, Tateishi R, Fujishima T, Akamatsu M, Koike Y, Obi S, Hamamura K, Sato S, Teratani T, Shiina S, Omata M. Hepatogastroenterology; 2003 May 14; 50(54):2157-60. PubMed ID: 14696486 [Abstract] [Full Text] [Related]
7. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O. Clin Oncol (R Coll Radiol); 2007 Apr 14; 19(3):197-203. PubMed ID: 17359907 [Abstract] [Full Text] [Related]
8. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients. Toyoda H, Kumada T, Kaneoka Y, Murakami Y. J Hepatol; 2008 Jan 14; 48(1):43-50. PubMed ID: 18023912 [Abstract] [Full Text] [Related]
9. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Clin Gastroenterol Hepatol; 2007 Aug 14; 5(8):938-45, 945.e1-4. PubMed ID: 17509946 [Abstract] [Full Text] [Related]
10. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Mahmood S, Niiyama G, Kamei A, Izumi A, Nakata K, Ikeda H, Suehiro M, Kawanaka M, Togawa K, Yamada G. Liver Int; 2005 Apr 14; 25(2):220-5. PubMed ID: 15780042 [Abstract] [Full Text] [Related]
11. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging. Gonzalez SA, Jacobson IM. Am J Gastroenterol; 2005 Apr 14; 100(4):977-8. PubMed ID: 15784045 [No Abstract] [Full Text] [Related]
12. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model. Tanaka J, Kumada H, Ikeda K, Chayama K, Mizui M, Hino K, Katayama K, Kumagai J, Komiya Y, Miyakawa Y, Yoshizawa H. J Med Virol; 2003 Jul 14; 70(3):378-86. PubMed ID: 12767000 [Abstract] [Full Text] [Related]
13. [Long-term prognosis of chronic B and C viral hepatitis]. Ohlen J, Liegl JM, Selmair H. Leber Magen Darm; 1995 Sep 14; 25(5):205-10. PubMed ID: 7500807 [Abstract] [Full Text] [Related]
14. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G. Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330 [Abstract] [Full Text] [Related]
15. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Shindo M, Ken A, Okuno T. Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234 [Abstract] [Full Text] [Related]
16. [Hepatitis B and C: natural course of disease]. Vince A. Acta Med Croatica; 2005 May 01; 59(5):389-92. PubMed ID: 16381232 [Abstract] [Full Text] [Related]
17. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role? Kara B, Doran F, Kara IO, Akkiz H, Sandikci M. Int J Clin Pract; 2008 Aug 01; 62(8):1206-11. PubMed ID: 18284441 [Abstract] [Full Text] [Related]
18. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690 [Abstract] [Full Text] [Related]
19. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD. Liver Int; 2005 Apr 15; 25(2):236-41. PubMed ID: 15780044 [Abstract] [Full Text] [Related]
20. Family physicians' knowledge and screening of chronic hepatitis and liver cancer. Ferrante JM, Winston DG, Chen PH, de la Torre AN. Fam Med; 2008 May 15; 40(5):345-51. PubMed ID: 18465284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]